Follicular Lymphoma
Showing NaN - NaN of 32
Follicular Lymphoma Trial in Houston (Bendamustine, Mitoxantrone, Rituximab)
Terminated
- Follicular Lymphoma
- Bendamustine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 1, 2020
Follicular Lymphoma Trial in Worldwide (PF-05280586, MabThera®)
Completed
- Follicular Lymphoma
- PF-05280586
- MabThera®
-
Anaheim, California
- +422 more
Jun 18, 2019
CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma Trial in Houston (procedure, biological, drug)
Completed
- CD20 Positive
- +6 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
May 30, 2019
Follicular Lymphoma, B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (Ibrutinib, rituximab)
Completed
- Follicular Lymphoma
- +2 more
-
Burbank, California
- +11 more
Mar 26, 2019
Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564
Completed
- Acute Myelogenous Leukemia
- +3 more
- BMS-936564 (Anti-CXCR4)
-
Birmingham, Alabama
- +10 more
Mar 5, 2015
B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)
Completed
- B-Cell Lymphoma
- +2 more
- VELCADE and rituximab
-
Los Angeles, California
- +12 more
Feb 7, 2008